Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-17

Clinical Trial Update: High-dose vs. Standard-dose Cephalexin for Cellulitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing high-dose versus standard-dose cephalexin for cellulitis has completed, with results posted on 2025-01-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cephalexin (Cephalexin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Cellulitis | Phase 4 | Status: COMPLETED | Results posted: 2025-01-17